methyl 3-((1r,4R)-N-((1r,4R)-4-hydroxycyclohexyl)-4-methylcyclohexanecarboxamido)thiophene-2-carboxylate | 914780-54-4

• 分子结构分类: 有机化合物 - 有机杂环化合物
• 英文名称: methyl 3-((1r,4R)-N-((1r,4R)-4-hydroxycyclohexyl)-4-methylcyclohexanecarboxamido)thiophene-2-carboxylate
• 英文别名: 3-[(trans-4-hydroxy-cyclohexyl)-(trans-4-methyl-cyclohexane-carbonyl)-amino]-thiophene-2-carboxylic acid methyl ester
• CAS: 914780-54-4
• 化学式: C₂₀H₂₉NO₄S
• 分子量: 379.521
• InChiKey: FUFKLFUHAOZTRC-BIAGXBKMSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.0
• 重原子数：
  26.0
• 可旋转键数：
  4.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  66.84
• 氢给体数：
  1.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  methyl 3-((1r,4R)-N-((1r,4R)-4-hydroxycyclohexyl)-4-methylcyclohexanecarboxamido)thiophene-2-carboxylate 在 咪唑 、 正丁基锂 、 异丙基氯化镁 、 二异丙胺 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 为溶剂， 反应 15.5h， 生成 methyl 3-((1r,4R)-N-((1r,4R)-4-(tert-butyldimethylsilyloxy)cyclohexyl)-4-methylcyclohexanecarboxamido)-5-(1-(trifluoromethyl)cyclobutanecarbonyl)thiophene-2-carboxylate
  参考文献：
  名称：

  Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection

  摘要：

  Investigation of thiophene-2-carboxylic acid HCV NS5B site II inhibitors, guided by measurement of cell culture medium binding, revealed the structure activity relationships for intrinsic cellular potency. The pharmacokinetic profile was enhanced through incorporation of heterocyclic ethers on the N-alkyl substituent. Hydroxyl groups were incorporated to modulate protein binding. Intrinsic potency was further improved through enantiospecific introduction of an olefin in the N-acyl motif, resulting in the discovery of the phase 2 clinical candidate GS-9669. The unexpected activity of this compound against the clinically relevant NS5B M423T mutant, relative to the wild type, was shown to arise from both the N-alkyl substituent and the N-acyl group.

  DOI：

  10.1021/jm401420j
• 作为产物：
  描述：

  3-氨基-2-噻吩甲酸甲酯 在 吡啶 、 盐酸 、 sodium tetrahydroborate 、 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 甲苯 为溶剂， 反应 54.0h， 生成 methyl 3-((1r,4R)-N-((1r,4R)-4-hydroxycyclohexyl)-4-methylcyclohexanecarboxamido)thiophene-2-carboxylate
  参考文献：
  名称：

  Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection

  摘要：

  Investigation of thiophene-2-carboxylic acid HCV NS5B site II inhibitors, guided by measurement of cell culture medium binding, revealed the structure activity relationships for intrinsic cellular potency. The pharmacokinetic profile was enhanced through incorporation of heterocyclic ethers on the N-alkyl substituent. Hydroxyl groups were incorporated to modulate protein binding. Intrinsic potency was further improved through enantiospecific introduction of an olefin in the N-acyl motif, resulting in the discovery of the phase 2 clinical candidate GS-9669. The unexpected activity of this compound against the clinically relevant NS5B M423T mutant, relative to the wild type, was shown to arise from both the N-alkyl substituent and the N-acyl group.

  DOI：

  10.1021/jm401420j

文献信息

• Compounds and methods for the treatment or prevention of Flavivirus infections
  申请人：Denis Real

  公开号：US20060276533A1

  公开（公告）日：2006-12-07

  Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R 1 , X, Y, Y 1 , and Z are as defined herein, are useful for treating flaviviridae viral infections.

  公式I所代表的化合物或其药用可接受的盐和溶剂化物，其中R1、X、Y、Y1和Z的定义如本文所述，可用于治疗黄病毒科病毒感染。
• COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  申请人：DENIS Real

  公开号：US20100093775A1

  公开（公告）日：2010-04-15

  Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R 1 , X, Y, Y 1 , and Z are as defined herein, are useful for treating flaviviridae viral infections.

  式I所代表的化合物或其药学上可接受的盐和溶剂化物，其中R1、X、Y、Y1和Z的定义如本文所述，可用于治疗黄病毒科病毒感染。
• Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
  申请人：Denis Real

  公开号：US20120164103A1

  公开（公告）日：2012-06-28

  Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R 1 , X, Y, Y 1 , and Z are as defined herein, are useful for treating flaviviridae viral infections.

  以式子I所代表的化合物或其药学上可接受的盐和溶剂化物，其中R1，X，Y，Y1和Z的定义如本文所述，可用于治疗黄病毒科病毒感染。
• Compounds and methods for the treatment of prevention of Flavivirus infections
  申请人：ViroChem Pharma Inc.

  公开号：US07569600B2

  公开（公告）日：2009-08-04

  Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviviridae viral infections.

  式I所代表的化合物：或其药学上可接受的盐和溶剂化物，其中R1、X、Y、Y1和Z的定义如本文所述，可用于治疗黄病毒科病毒感染。
• Compounds and methods for the treatment or prevention of flavivirus infections
  申请人：Denis Real

  公开号：US08674118B2

  公开（公告）日：2014-03-18

  Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviviridae viral infections.

  公式I所代表的化合物或其药学上可接受的盐和溶剂，其中R1，X，Y，Y1和Z的定义如本文所述，对于治疗黄病毒科病毒感染是有用的。